Literature DB >> 2051063

Exocrine pancreatic function and chronic unexplained dyspepsia. A case-control study.

R C Smith1, N J Talley, O F Dent, M Jones, S L Waller.   

Abstract

The aim of this study was to determine the prevalence of diminished mean tryptic activity (MTA) in duodenal juice of patients with nonulcer dyspepsia following injection of a Lundh test meal. Two separate studies were undertaken. The first examined a consecutive group of 100 patients with suspected pancreatic disease referred over a period of 2 yr. In these patients, receiver-operating-characteristic analysis was used to determine the point of best discrimination, which occurred at 7 microEq/mL/min when non-pancreatic disease patients were compared with those with chronic pancreatitis or pancreatic cancer. The second study involved 22 patients with endoscopically confirmed nonulcer dyspepsia. The MTA for the patients with unexplained dyspepsia did not differ from 17 healthy controls, but a further 16 pancreatic disease control patients had significantly decreased values (p less than 0.01). Six patients with unexplained dyspepsia (27%) had an MTA of 7 microEq/min/mL or less, indicating impaired pancreatic function, which was more frequent than in healthy controls (p = 0.02). These six patients had significantly different symptoms, being more likely to have pain radiating through to the back (p = 0.017) and pain waking them from sleep (p = 0.002), and less likely to have postprandial pain (p = 0.045). It was of interest that the alcohol intake was not greater in these six patients. It is concluded that pancreatic disease may explain the symptoms of some patients with nonulcer dyspepsia.

Entities:  

Mesh:

Year:  1991        PMID: 2051063     DOI: 10.1007/bf02924544

Source DB:  PubMed          Journal:  Int J Pancreatol        ISSN: 0169-4197


  20 in total

1.  The Lundh test in the diagnosis of pancreatic disease: a review of five years' experience.

Authors:  A Mottaleb; F Kapp; E C Noguera; T D Kellock; H S Wiggins; S L Waller
Journal:  Gut       Date:  1973-11       Impact factor: 23.059

Review 2.  Assessment of exocrine pancreatic function by duodenal intubation.

Authors:  V L Go; E P Dimagno
Journal:  Clin Gastroenterol       Date:  1984-09

3.  Clinical presentation of patients with "dyspepsia". Detailed symptomatic study of 360 patients.

Authors:  J C Horrocks; F T De Dombal
Journal:  Gut       Date:  1978-01       Impact factor: 23.059

4.  Introduction to sample size determination and power analysis for clinical trials.

Authors:  J M Lachin
Journal:  Control Clin Trials       Date:  1981-06

5.  The association between non-ulcer dyspepsia and other gastrointestinal disorders.

Authors:  N J Talley; D W Piper
Journal:  Scand J Gastroenterol       Date:  1985-09       Impact factor: 2.423

6.  Prognosis of chronic unexplained dyspepsia. A prospective study of potential predictor variables in patients with endoscopically diagnosed nonulcer dyspepsia.

Authors:  N J Talley; D McNeil; A Hayden; C Colreavy; D W Piper
Journal:  Gastroenterology       Date:  1987-04       Impact factor: 22.682

7.  Association between duodenal bulb ulceration and reduced exocrine pancreatic function.

Authors:  S Schulze; N Thorsgaard Pedersen; M J Jørgensen; K M Møllmann; S J Rune
Journal:  Gut       Date:  1983-09       Impact factor: 23.059

8.  Discriminant value of dyspeptic symptoms: a study of the clinical presentation of 221 patients with dyspepsia of unknown cause, peptic ulceration, and cholelithiasis.

Authors:  N J Talley; D McNeil; D W Piper
Journal:  Gut       Date:  1987-01       Impact factor: 23.059

9.  The pseudo-ulcer syndrome. A clinical, radiographic and statistical follow-up study of patients with ulcer symptoms but no demonstrable ulcer in the stomach or duodenum.

Authors:  E Krag
Journal:  Dan Med Bull       Date:  1969-01

10.  The Lundh test: a review of its clinical use in the diagnosis of pancreatic disease.

Authors:  S L Waller; A Smithies; F Kapp; M Loyaza; E C Noguera; D Philippakos; H G Stacher
Journal:  Aust N Z J Med       Date:  1981-10
View more
  4 in total

1.  Trypsin may be associated with duodenal eosinophils through the expression of PAR2 in early chronic pancreatitis and functional dyspepsia with pancreatic enzyme abnormalities.

Authors:  Shuhei Agawa; Seiji Futagami; Hiroshi Yamawaki; Rina Tsushima; Kazutoshi Higuchi; Mayu Habiro; Rie Kawawa; Yasuhiro Kodaka; Nobue Ueki; Yoshiyuki Watanabe; Katya Gudis; Rhuji Ohashi; Katsuhiko Iwakiri
Journal:  PLoS One       Date:  2022-10-20       Impact factor: 3.752

2.  Efficacy of camostat mesilate against dyspepsia associated with non-alcoholic mild pancreatic disease.

Authors:  Jin Kan Sai; Masafumi Suyama; Yoshihiro Kubokawa; Yuji Matsumura; Koichi Inami; Sumio Watanabe
Journal:  J Gastroenterol       Date:  2009-10-30       Impact factor: 7.527

3.  Epigastric pain syndrome accompanying pancreatic enzyme abnormalities was overlapped with early chronic pancreatitis using endosonography.

Authors:  Satomi Hashimoto; Seiji Futagami; Hiroshi Yamawaki; Keiko Kaneko; Yasuhiro Kodaka; Mako Wakabayashi; Noriko Sakasegawa; Shuhei Agawa; Kazutoshi Higuchi; Teppei Akimoto; Nobue Ueki; Tetsuro Kawagoe; Hitomi Sato; Katsuhisa Nakatsuka; Kaya Gudis; Chiaki Kawamoto; Takashi Akamizu; Choitsu Sakamoto; Katsuhiko Iwakiri
Journal:  J Clin Biochem Nutr       Date:  2017-08-18       Impact factor: 3.114

4.  Comparison of clinical symptoms, gastric motility and fat intake in the early chronic pancreatitis patients with anti-acid therapy-resistant functional dyspepsia patients.

Authors:  Mako Wakabayashi; Seiji Futagami; Hiroshi Yamawaki; Atsushi Tatsuguchi; Keiko Kaneko; Shuhei Agawa; Kazutoshi Higuchi; Noriko Sakasegawa; Makoto Murakami; Teppei Akimoto; Yasuhiro Kodaka; Nobue Ueki; Kaya Gudis; Chiaki Kawamoto; Takashi Akamizu; Choitsu Sakamoto; Katsuhiko Iwakiri
Journal:  PLoS One       Date:  2018-11-07       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.